
|Podcasts|April 23, 2021
Podcast: First drug-eluting contact lens approved in Japan
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.
Advertisement
Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses. This lens was recently approved in Japan for vision correction and allergy symptom relief. Brian Pall, OD, MS, FAAO, director of clinical science at Johnson & Johnson Vision Care, discusses the lens and its technology.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Some red light therapy devices may exceed safety levels for myopia control, study suggests
2
No myopia progression reported on average in 6-month trial assessing MiYOSMART iQ spectacle lenses
3
What to know about the most recent treatment and management developments in AMD
4
American College of Physicians policy paper advocates for scrapping the term "provider"
5




























